This page shows the latest Delinia news and features for those working in and with pharma, biotech and healthcare.
Previous deals saw Celgene swoop on Delinia and its Treg therapies for autoimmune conditions, paying $300m upfront for the company, while Eli Lilly paid $150m for co-development rights to a ... Delinia’s DEL106 acts as an interleukin-2 (IL-2) mutein Fc
Celgene has made another bolt-on acquisition, paying $300m upfront and $475m in milestones for Delinia and its immunology and inflammation programmes. ... The scale of the deal is eye-opening given that Delinia's lead candidate is still in preclinical
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
960. Valeant. Sanpower Group. Divestment. Dendreon equity interest. 820. Delinia. Celgene.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
chief executive officer of Delinia until its sale to Celgene.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...